1 | Acthar high dose (80 U) | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 49 49 |
2 | Administration of a high dose of desipramine | [1] Desipramine Desipramine | [2] D00812
D00812
,
D07791
| [2] SLC6A2 SLC6A2, SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 156 156 |
3 | Ambrisentan - high dose | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
4 | AXO-AAV-GM2 High Dose | - | - | - | - | [1] 19 19 |
5 | BI 655064 high dose | - | - | - | - | [1] 46 46 |
6 | BIIL 284 BS high dose | - | - | - | - | [1] 46 46 |
7 | BIIL 284 BS, high dose | - | - | - | - | [1] 299 299 |
8 | BIIL 284 BS, high dose, adult patients | - | - | - | - | [1] 299 299 |
9 | BIIL 284 BS, high dose, pediatric patients | - | - | - | - | [1] 299 299 |
10 | BIRB 796 BS, high dose | - | - | - | - | [1] 46 46 |
11 | BLI-1300 high dose | - | - | - | - | [1] 96 96 |
12 | Brazikumab high dose | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
13 | Clobazam High Dose | [1] Clobazam Clobazam | [1] D01253
D01253
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 |
14 | CVN424 High Dose | - | - | - | - | [1] 6 6 |
15 | CVT-301 High Dose | - | - | - | - | [1] 6 6 |
16 | DNS-7801 (high dose) | - | - | - | - | [1] 6 6 |
17 | Elamipretide (high dose) | [1] Elamipretide Elamipretide | [1] D10925
D10925
| - | - | [1] 21 21 |
18 | EUR-1008 (APT-1008) High Dose | - | - | - | - | [1] 298 298 |
19 | Fentanyl (High Dose) | [1] Fentanyl Fentanyl | [2] D00320
D00320
,
D01399
| [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 215 215 |
20 | High dose | - | - | - | - | [1] 97 97 |
21 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | [1] 6 6 |
22 | High dose ANAVEX2-73 | - | - | - | - | [1] 6 6 |
23 | High Dose Aspirin (1300 mg/day) | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
24 | High dose BIBF 1120 twice daily | - | - | - | - | [1] 85 85 |
25 | High Dose Budesonide | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
26 | High dose budesonide suspension | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
27 | High dose budesonide tablet | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
28 | High dose Dexamethasone pulses | [1] Dexamethasone Dexamethasone | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 63 63 |
29 | High dose lactulose | [1] Lactulose Lactulose | [1] D00352
D00352
| - | - | [1] 291 291 |
30 | High dose levodopa | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
31 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 |
32 | High Dose MT-1303 | - | - | - | - | [1] 97 97 |
33 | High dose of BIIL 284 BS tablets | - | - | - | - | [1] 46 46 |
34 | High dose of budesonide | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 299 299 |
35 | High dose ORTD-1 | - | - | - | - | [1] 46 46 |
36 | High dose TSO | - | - | - | - | [1] 96 96 |
37 | High dose vehicle control | - | - | - | - | [1] 46 46 |
38 | High Dose-VIS649 | - | - | - | - | [1] 66 66 |
39 | High doses of Thiamine y Biotin | [2] Biotin Biotin, Thiamine | [2] D00029
D00029
,
D08580
| - | - | [1] 8 8 |
40 | HMPL-004 high dose | - | - | - | - | [1] 97 97 |
41 | IgPro20 (high dose) | - | - | - | - | [1] 14 14 |
42 | KPS-0373, High dose | - | - | - | - | [1] 18 18 |
43 | KW-6356 High Dose | - | - | - | - | [1] 6 6 |
44 | LiRIS low dose and LiRIS high dose | - | - | - | - | [1] 226 226 |
45 | LX3305 high dose | - | - | - | - | [1] 46 46 |
46 | M5049 high dose | - | - | - | - | [1] 49 49 |
47 | MEDI7183 high dose | - | - | - | - | [1] 97 97 |
48 | MMX Mesalamine/Mesalazine (High Dose) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
49 | MT-1303 High dose | - | - | - | - | [1] 49 49 |
50 | MT-7117 High Dose | - | - | - | - | [1] 254 254 |
51 | MultiStem high dose | [1] MultiStem MultiStem | - | - | - | [1] 97 97 |
52 | Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT) | - | - | - | - | [1] 49 49 |
53 | OCU400 High Dose | - | - | - | - | [1] 90 90 |
54 | PF-06649751 high dose (15 mg QD) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
55 | PXT3003 High Dose | - | - | - | - | [1] 10 10 |
56 | Ravicti high dose | [1] Glycerol phenylbutyrate Glycerol phenylbutyrate | [1] D10127
D10127
| - | - | [1] 299 299 |
57 | SA001 High dose | - | - | - | - | [1] 53 53 |
58 | SEN0014196 (High Dose) | - | - | - | - | [1] 8 8 |
59 | SHR1459 High Dose | - | - | - | - | [1] 222 222 |
60 | TAS5315 high dose | - | - | - | - | [1] 46 46 |
61 | Vitamin D3 - high dose | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 6 6 |
62 | YRA-1909 high dose | - | - | - | - | [1] 46 46 |